The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Williams Lewis T since 2014.
The trader's CIK number is 1475714.
At the time of the last reporting, Williams Lewis T was the President and CEO of Five Prime Therapeutics, Inc.. (stock ticker symbol FPRX).
Also see all insider trading activities at Five Prime Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2018 | FPRX | 0 | $0 | 0 | $0 | 91,217 | $415,949 |
| 2016 | FPRX | 0 | $0 | 253,349 | $10,526,009 | 334,649 | $1,832,970 |
| 2015 | FPRX | 0 | $0 | 150,000 | $3,878,666 | 0 | $0 |
| 2014 | FPRX | 0 | $0 | 50,000 | $654,884 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-11-05 | FPRX | Option Ex | 91,217 | 4.56 | 415,949 |
| 2016-12-23 | FPRX | Option Ex | 30,000 | 6.37 | 191,100 |
| 2016-12-23 | FPRX | Sale | 30,000 | 50.76 | 1,522,650 |
| 2016-05-06 | FPRX | Option Ex | 81,300 | 1.23 | 99,999 |
| 2016-04-20 | FPRX | Option Ex | 550 | 8.49 | 4,669 |
| 2016-04-21 | FPRX | Option Ex | 48,121 | 8.49 | 408,547 |
| 2016-04-20 | FPRX | Sale | 550 | 48.00 | 26,400 |
| 2016-04-21 | FPRX | Sale | 48,121 | 48.05 | 2,312,214 |
| 2016-04-15 | FPRX | Sale | 1,405 | 48.00 | 67,440 |
| 2016-04-15 | FPRX | Option Ex | 1,405 | 8.49 | 11,928 |
| 2016-04-14 | FPRX | Option Ex | 2,725 | 8.49 | 23,135 |
| 2016-04-14 | FPRX | Sale | 2,725 | 48.00 | 130,800 |
| 2016-04-05 | FPRX | Option Ex | 25,949 | 8.49 | 220,307 |
| 2016-04-06 | FPRX | Option Ex | 26,852 | 8.49 | 227,973 |
| 2016-04-05 | FPRX | Sale | 25,949 | 43.00 | 1,115,807 |
| 2016-04-06 | FPRX | Sale | 26,852 | 43.17 | 1,159,200 |
| 2016-03-29 | FPRX | Option Ex | 9,215 | 6.89 | 63,491 |
| 2016-03-30 | FPRX | Option Ex | 14,044 | 6.89 | 96,763 |
| 2016-03-29 | FPRX | Sale | 9,215 | 40.01 | 368,692 |
| 2016-03-30 | FPRX | Sale | 14,044 | 40.02 | 562,040 |
| 2016-03-02 | FPRX | Option Ex | 23,259 | 6.89 | 160,254 |
| 2016-03-02 | FPRX | Sale | 23,259 | 36.01 | 837,556 |
| 2016-02-04 | FPRX | Option Ex | 71,229 | 4.56 | 324,804 |
| 2016-02-04 | FPRX | Sale | 71,229 | 34.02 | 2,423,210 |
| 2015-10-15 | FPRX | Sale | 72,352 | 27.40 | 1,982,444 |
| 2015-09-21 | FPRX | Sale | 2,648 | 22.06 | 58,422 |
| 2015-06-22 | FPRX | Sale | 75,000 | 24.50 | 1,837,800 |
| 2014-10-31 | FPRX | Sale | 11,901 | 13.09 | 155,748 |
| 2014-11-03 | FPRX | Sale | 13,559 | 13.05 | 177,012 |
| 2014-11-04 | FPRX | Sale | 7,143 | 13.11 | 93,651 |
| 2014-10-28 | FPRX | Sale | 9,734 | 13.04 | 126,911 |
| 2014-10-29 | FPRX | Sale | 1,825 | 13.03 | 23,783 |
| 2014-10-30 | FPRX | Sale | 5,838 | 13.32 | 77,779 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Williams Lewis T (President and CEO of Five Prime Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.